Review Product Marketing Authorisation For Human Use "latanoprost Sandoz».

Original Language Title: Modifica dell'autorizzazione all'immissione in commercio delmedicinale per uso umano «Latanoprost Sandoz».

Read the untranslated law here: http://www.gazzettaufficiale.it/atto/serie_generale/caricaArticoloDefault/originario?atto.dataPubblicazioneGazzetta=2015-02-10&atto.codiceRedazionale=15A00816&elenco30giorni=false&atto.tipoProvvedimento=DECRETO

Retrieved 18 January 14, 2015 V&A/variation of Authorization determines: B.I.. z relative to medicine: LATANOPROST SANDOZ European procedure: DE/H/2076/001/II/008 Mah: SANDOZ SPA is hereby amended as follows: update of the DMF manufacturer (Yonsung Fine Chemicals Co. Ltd.) (applicant's open part version 5.0 (05/2011), restricted part version 4.0) for the active ingredient of latanoprost in relation to authorisations authorised pack sizes in Italy following the mutual recognition procedure.
Inventory disposal lots already products can be kept on the market until the expiration date printed on the label of the medicinal product in accordance with art. 1, paragraph 5, of the causes of the April 14, 2014 # 371 AIFA published in Official Gazette No 101 of May 3, 2014.
Date of determination: from the day following that of its publication, to decompress, in Gazzetta Ufficiale della Repubblica Italiana.